Continuous intrathecal baclofen infusion by a programmable pump in 131 consecutive patients with severe spasticity of spinal origin

Neuromodulation

Volumn 5, Issue 1, 2002, Pages 16-24

  Ordia, Joe I ^a,b   Fischer, Edward ^a   Adamski, Ellen ^a   Chagnon, Kimberly G ^a   Spatz, Edward L ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Baclofen; Multiple sclerosis; Programmable pump; Spasticity; Spinal cord injury

Indexed keywords

BACLOFEN;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIAL MENINGITIS; BRADYCARDIA; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG EFFICACY; DRUG SAFETY; ERECTILE DYSFUNCTION; FEMALE; HUMAN; HYPOTENSION; INFUSION PUMP; MAJOR CLINICAL STUDY; MALE; MUSCLE HYPOTONIA; NAUSEA; PATIENT SELECTION; PHYSICAL ACTIVITY; POSTOPERATIVE COMPLICATION; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SLEEP; SPASTICITY; TREATMENT OUTCOME; URINE RETENTION; VERTIGO;

EID: 0036164676     PISSN: 10947159     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1403.2002._2004.x     Document Type: Article

References (37)

1. Symposium synopsis
2. Baclofen for spasticity in multiple sclerosis. Double-blind crossover and three-year study
3. Drug therapy: Spasticity
4. The assessment of drug treatment of spastic gait
5. Baclofen (Lioresal) in the long-term management of spasticity
6. Treatment of spasticity
7. Intrathecal baclofen for long-term treatment of spasticity: A multi-centre study
8. Continuous intrathecal baclofen for severe spasticity
9. Long-term intrathecal baclofen infusion for treatment of spasticity
10. Intrathecal baclofen for severe spasticity
11. Chronic intrathecal delivery of baclofen by a programmable pump for the treatment of severe spasticity
12. Midthoracic catheter tip placement for intrathecal baclofen administration in children with quadriparetic spasticity
13. Intrathecal baclofen for intractable spasticity of spinal origin: Results of a long-term multicenter study
14. Intrathecal baclofen for severe spinal spasticity
15. Control of spasticity by implantable continuous flow morphine pump
16. Control of intractable spasticity with intrathecal morphine sulfate
17. Intrathecal fentanyl alleviates spasticity in the presence of tolerance to intrathecal baclofen
18. Indium-111 DTPA flow study to evaluate surgically implanted drug pump delivery system
19. Effects of intrathecal baclofen on voluntary motor control in spastic paresis
20. Effect of intrathecal baclofen on bladder and sphincter function
21. Voiding dysfunction in patients with spastic paraplegia: Urodynamic evaluation and response to continuous intrathecal baclofen
22. Effect of intrathecal baclofen delivered by an implanted programmable pump on health related quality of life in patients with severe spasticity
23. Long-term intrathecal baclofen therapy in patients with intractable spasticity
24. Intrathecal baclofel therapy for adults with spinal spasticity: Therapeutic efficacy and effect on hospital admissions
25. Side effects of chronic intrathecal baclofen on erection and ejaculation in patients with spinal cord lesions
26. Epileptic seizures associated with intrathecal baclofen application
27. Physostigmine in the treatment of intrathecal baclofen overdose. Report of three cases
28. Intrathecal baclofen overdose: Report of 7 events in 5 patients and review of the literature
29. Cathieter systems for intrathecal drug delivery
30. Staphylococcal meningitis following Synchromed intrathecal pump implant: A case report
31. Pseudomonas aeruginosa infection in an intrathecal baclofen pump: Successful treatment with adjunct intra-reservoir gentamicin
32. Continuous intrathecal pump infusion of baclofen with antibiotic drugs for treatment of pumpassociated meningitis. Case report
33. Lasting reduction of severe spasticity after ending chronic treatment with intrathecal baclofen
34. Treatment of spasticity with the intrathecal administration of baclofen
35. Intrathecal baclofen